Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2025-09-03

Clinical Trial Update: DELIVER Study in a Population With Clinical Suspicion of Liver Cirrhosis

View source ↗

Summary

The DELIVER clinical trial from Owlstone Ltd is currently recruiting participants with a clinical suspicion of liver cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Owlstone Ltd | Conditions: Cirrhosis, Liver | Status: RECRUITING